|
Market Cap (5-Jul) $2,416,092 (1,016th) |
Close (30-Jun) $0.016 |
Volume (30-Jun) 5,525,026 |
Shortsold (24-Dec) 11,970 (0.01%) (590th) |
|
52w High $0.082 |
52w Low $0.011 |
P/E - |
EPS -0.05 |
IBX released this announcement to the ASX on 17 March 2022, 10:24. The announcement is marked as price sensitive, and is 2 page(s) in length and 118.5kb in size.
You can view all announcements from IBX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IBX was 0.001% short sold according to ASIC data. It was ranked the 748th most shorted stock on the ASX. It is now ranked as the 590th most shorted stock on the ASX with 0.006% of total shares short sold as of the latest reported data (24 December 2024).
| Other Recent Announcements from IBX | |
|---|---|
| Expanded collaboration with Siemens Healthineers to US | 28 June 2023, 8:49 |
| Imagion to complete the MagSense HER2 Phase 1 Study | 21 June 2023, 8:27 |
| Imagion Announces New CEO | 19 June 2023, 8:31 |
| First-in-human Study Progress Update | 17 March 2022, 10:24 |
| Revised Appendix 4G | 3 March 2022, 16:09 |
| Full Year Investor Presentation | 24 February 2022, 14:00 |
| Full Year Results Release | 24 February 2022, 14:00 |
You must be logged in to post a reply.
Imagion Biosystems 